French Industry Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.

Press releases published on April 13, 2026

Apr. 13, 2026

PulseForge Achieves Sub-10 µm Silicon Breakthrough in Ultra-Thin Wafer Processing with Photonic Debonding

Indeterminate EIN Presswire

Apr. 13, 2026

Hannover House sets ambitious production slate for launch at Cannes Festival

Indeterminate EIN Presswire

Apr. 13, 2026

Vol de marchandises : peu d’inquiétudes de la part des gestionnaires de flotte malgré les risques

Indeterminate EIN Presswire

Apr. 13, 2026

New SOCIETIES Edition Spotlights AI, Wellness and Design in the Shift Toward Intentional Luxury

Indeterminate EIN Presswire

Apr. 13, 2026

Soil Management Market Is Going to Boom – Growth Opportunities Through 2033 | Bayer Crop Science AG, Novozymes

Indeterminate EIN Presswire

Apr. 13, 2026

Doyield repositionne le débat OTA à l’ère de l’IA dans un podcast de 10 minutes hotels qui bouscule les idées reçues

Indeterminate EIN Presswire

Apr. 13, 2026

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

Indeterminate GlobeNewswire

Apr. 13, 2026

Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis

Indeterminate GlobeNewswire

Apr. 13, 2026

Technip Energies launches its 2026 Employee Share Offering

Indeterminate GlobeNewswire

Apr. 13, 2026

Technip Energies lance son offre d'actionnariat salarié 2026

Indeterminate GlobeNewswire

Apr. 13, 2026

Ministers and Members of Parliament at Paris Blockchain Week 2026: A Historic Signal for the Institutionalization of Crypto-Assets

Indeterminate GlobeNewswire

Apr. 13, 2026

Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada

Indeterminate GlobeNewswire

Apr. 13, 2026

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer

Indeterminate GlobeNewswire

Apr. 13, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 13, 2026

Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants

Indeterminate GlobeNewswire